CM Hospitalar (VVEO3) Q4 2024 earnings summary

Executive summary

• Achieved significant operational integration after over 25 acquisitions since 2017, consolidating 18 legal entities and reducing ERP systems from 23 to 13, with a focus on system and process unification in 2023-2024.

• Shifted strategy from rapid growth to operational execution and efficiency for 2025, prioritizing cash generation, margin recovery, and cost reduction.

• Leadership team restructured, with new executives in key roles and a move to more centralized decision-making and governance.

Financial highlights

• Net revenue for Q4 2024 was R$2,936.8 million, with annual revenue of R$11,583.4 million, up 4.5% from 2023.

• Adjusted EBITDA reached R$164.1 million in Q4 and R$652.1 million for the year, with a margin of 5.6%.

• Free cash flow turned positive at R$206.2 million in 2024, reversing a R$892.5 million cash burn in 2023.

• Adjusted net loss for 2024 was R$90 million, impacted by non-recurring write-downs.

Outlook and guidance

• 2025 will focus on execution, operational efficiency, margin recovery, and operating cash generation rather than top-line growth.

• Expectation of higher cash generation in 2025, with normalized working capital and improved cash cycle.

• Action plans underway to attract new clients, expand partnerships, and improve profitability in underperforming segments.

• Anticipate margin and ROIC improvement, targeting a minimum ROIC of 15% by mid-2025.